Tag: digital pathology imaging

Philips digital pathology system scores huge success as FDA clears digital path for primary diagnosis

This is an excerpt from a 1,400-word article in the April 24, 2017, issue of THE DARK REPORT. The complete article is available for a limited time to all readers, and available at all times to paid members of the Dark Intelligence Group.
CEO SUMMARY: Proponents of digital pathology systems and whole slide imaging achieved a milestone

View Article

DMetrix, Bio-Reference Labs, US Clinical Labs, Vidalia Laboratory Services

DMETRIX PREPARES TO INTRODUCE CHEAPER PATHOLOGY SCANNER
PATHOLOGISTS MAY SOON BE ABLE TO PURCHASE a smaller and less expensive digital scanning system that fits on a microscope. DMetrix, Inc., of Tucson, Arizona, is working to downsize its flagship digital pathology imaging system.

Pixuan “Joe” Zhou, Ph.D, is President of DMetrix. He recently told a reporter for the

View Article

Growing Role for Digital Image Analysis in Pathology

CEO SUMMARY: For more than three years, pathologists at Washington University in St. Louis have worked with several different scanning products and digital pathology systems. Step-by-step, the Pathology Department has learned important lessons in how to capture digital images, archive them, then make them available on demand to the pathologists. WU currently captures images from

View Article

FDA Advisory Panel Convenes To Assess Whole Slide Imaging

Editor’s Note: Guest writer Martin Perry attended the FDA’s advisory panel on digital pathology conducted earlier this month. He is CEO of The Perry Group and has extensive experience in imaging and healthcare. He offers his insights from the FDA proceedings on digital pathology imaging.

DIGITAL PATHOLOGY CONTINUES to gain acceptance at a steady but measured

View Article

Scripps’ Tumor Board Finds Value in Digital Imaging of Slides

CEO Summary: When the Pathology Department at Scripps Memorial Hospital in La Jolla, California, was considering the purchase of a digital imaging system, it gained unlikely allies. Non-pathologist physicians participating in the department’s tumor boards advocated for the purchase after seeing a demonstration. Pathologists at Scripps are preparing for a future in which digital imaging

View Article

Siemens, BioImagene, Clarient University of Pennsylvania, Mayo Clinic

SIEMENS INVESTS IN DIGITAL PATHOLOGY, BUYS STAKE IN BIOIMAGENE
IMAGING AND RADIOLOGY GIANT SIEMENS just made an interesting investment in digital pathology systems. On October 16, Siemens Venture Capital (SVC) revealed that it had purchased a stake in BioImagene Inc. (www.bioimagene.com) of Cupertino, California. The amount of the investment was not disclosed.

The timing of this

View Article

Is Digital Path Imaging Ready for Prime Time?

CEO SUMMARY: Digital pathology imaging systems are finding uses in all phases of drug discovery (discovery, pre-clinical, clinical trials), as well as education, research, and clinical. One hurdle to widespread adoption of fully digitized, whole-slide pathology imaging systems is FDA clearance that allows the use of this technology for primary diagnosis. Executives at two of

View Article